Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.

@article{Hans2009EfficacyAT,
  title={Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.},
  author={Guy Hans and Rainer Sabatowski and Andreas Binder and Irmgard Boesl and Peter Rogers and Ralf Baron},
  journal={Current medical research and opinion},
  year={2009},
  volume={25 5},
  pages={
          1295-305
        }
}
OBJECTIVE Evaluation of long-term efficacy and safety of the 5% lidocaine medicated plaster for neuropathic pain symptoms in patients with post-herpetic neuralgia (PHN). MATERIALS AND METHODS Design - a 12-month, open-label, phase III study with an open-label extension conducted at 34 outpatient clinics in 12 European countries. Patients - aged >or=50 years, newly recruited (average pain intensity >or=4) or pre-treated with the 5% lidocaine medicated plaster in a previous study. Interventions… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 30 CITATIONS

Complications of Varicella Zoster Virus Reactivation

  • Current Treatment Options in Neurology
  • 2013
VIEW 15 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Treatment of the localized pain of postherpetic neuralgia.

  • Postgraduate medicine
  • 2010
VIEW 12 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED